1H-Imidazo[4,5-c]quinoline-1-butanamine, 4-amino-2-butyl-
CAS313350-31-1
1H-Imidazo[4,5-c]quinoline-1-butanamine, 4-amino-2-butyl- (CAS 313350-31-1, C18H25N5) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
- CAS No.
- 313350-31-1
- Formula
- C18H25N5
- Mol. weight
- 311.43 g/mol
Chemical Specifications
Identifiers
| CAS number | 313350-31-1 |
|---|---|
| Product name | 1H-Imidazo[4,5-c]quinoline-1-butanamine, 4-amino-2-butyl- |
| Chinese name | 1-(4-氨基丁基)-2-丁基-1H-咪唑并[4,5-C]喹啉-4-胺 |
| Molecular formula | C18H25N5 |
| Molecular weight | 311.43 g/mol |
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of 1H-Imidazo[4,5-c]quinoline-1-butanamine, 4-amino-2-butyl-?
The CAS Registry Number of 1H-Imidazo[4,5-c]quinoline-1-butanamine, 4-amino-2-butyl- is 313350-31-1.
What is the molecular formula and molecular weight of 1H-Imidazo[4,5-c]quinoline-1-butanamine, 4-amino-2-butyl-?
The molecular formula of 1H-Imidazo[4,5-c]quinoline-1-butanamine, 4-amino-2-butyl- is C18H25N5, and its molecular weight is 311.43 g/mol.
How can I request a quotation for 1H-Imidazo[4,5-c]quinoline-1-butanamine, 4-amino-2-butyl-?
Send an inquiry for 1H-Imidazo[4,5-c]quinoline-1-butanamine, 4-amino-2-butyl- (CAS 313350-31-1) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for 1H-Imidazo[4,5-c]quinoline-1-butanamine, 4-amino-2-butyl-
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.